Page last updated: 2024-09-03

tazobactam and sisomicin

tazobactam has been researched along with sisomicin in 3 studies

Compound Research Comparison

Studies (tazobactam)	Trials (tazobactam)	Recent Studies (post-2010) (tazobactam)	Studies (sisomicin)	Trials (sisomicin)	Recent Studies (post-2010) (sisomicin)
1,327	153	694	592	42	91

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T	1
Bassetti, M; Battaglini, D; Giacobbe, DR; Pelosi, P; Vena, A	1
Garcia, JA; Liang, SY; Long, B; Matlock, A; Moussavi, K	1

Reviews

2 review(s) available for tazobactam and sisomicin

Article	Year
The role of new antimicrobials for Gram-negative infections in daily clinical practice. Current opinion in infectious diseases, 2020, Volume: 33, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines	2020
Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections. Internal and emergency medicine, 2021, Volume: 16, Issue:8 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem; Sisomicin; Tazobactam; Tetracyclines	2021

Article

Year

The role of new antimicrobials for Gram-negative infections in daily clinical practice.

Current opinion in infectious diseases, 2020, Volume: 33, Issue:6

Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; beta-Lactams; Carbapenems; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Polymyxins; Sisomicin; Tazobactam; Tetracyclines

2020

Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections.

Internal and emergency medicine, 2021, Volume: 16, Issue:8

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem; Sisomicin; Tazobactam; Tetracyclines

2021

Other Studies

1 other study(ies) available for tazobactam and sisomicin

Article	Year
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2009